TP53 and breast carcinoma: Previous studies suggest that mutant-type p53 has an influence on the prognosis of patients in many cancers including breast carcinoma and is associated with tumor staging, multidrug resistance, response to chemotherapy or radiotherapy, postsurgery recurrence, and metastasis [4, 6, 20].